Skip to main content
. Author manuscript; available in PMC: 2018 Sep 1.
Published in final edited form as: Int J Cancer. 2017 May 31;141(5):952–957. doi: 10.1002/ijc.30786

Table 1.

Gender and age of BCC cases and controls from each GWAS.

Status n (%) Male (%) Age < 30 yr Age 30–45 Age 46–60 Age > 60
23andMe (n = 287,197) Cases 12945 (4.5) 6700 (52) 42 (0.3) 650 (5) 3194 (25) 9059 (70)
Controls 274252 (95.5) 148415 (54) 39673 (14) 83162 (30) 74977 (27) 76440 (28)
Harvard (n = 12,343)
Affy Cases 1777 (24.7) 834 (46.9) 5 (0.3) 500 (28.1) 978 (55.0) 294 (16.5)
Controls 5411 (75.3) 2385 (44.1) 43 (0.8) 2068 (38.2) 2533 (46.8) 767 (14.2)
Illumina Cases 1268 (25.6) 368 (29.0) 6 (0.5) 472 (37.2) 678 (53.5) 112 (8.8)
Controls 3685 (74.4) 1029 (27.9) 33 (0.9) 1681 (45.6) 1692 (45.9) 279 (7.6)
Omni Cases 1197 (24.4) 102 (42.9) 0 (0.0) 72 (30.2) 137 (57.6) 29 (12.2)
Controls 3706 (75.6) 1238 (33.4) 34 (0.9) 1671 (45.1) 1651 (44.5) 350 (9.4)
All Harvard Cases 4242 (24.9) 1649 (38.9) 15 (0.4) 1375 (32.4) 2301 (54.2) 551 (13.0)
Controls 12802 (75.1) 4652 (36.3) 110 (0.9) 5420 (42.3) 5876 (45.9) 1396 (10.9)
Combined meta-analysis (n = 299,480) Cases 17187 (5.6) 8349 (49) 57 (0.3) 2025 (12) 5495 (32) 9610 (56)
Controls 287054 (94.4) 153067 (53) 39783 (14) 88582 (31) 80853 (28) 77836 (27)

Counts and percentages for cases and controls (n (%)) of two GWASs data sets are listed above. We also report number and percentage of male subjects, subjects with age < 30 years, subjects with age 30–45 years, subjects with age 46–60 years, and subjects with age > 60 years. Harvard data set is further subdivided based on platform used for genotyping.